Wholesale of pharmaceutical and medical goods
LOVISENBERG UTVIKLING 3 AS
Revenue 2024
NOK 35.7m
Operating profit
NOK −1.4m
Equity
NOK 6.3m
Incorporated
2012
Share capital
NOK 100,000
Key figures · 2024
Current ratio
9.06
Equity ratio
89.0%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -3.9% | |
| Net margin (%%) | -3.7% | |
| Return on assets (%%) | -19.5% | |
| Likviditet | ||
| Current ratio | 9.06 | |
| Working capital | 6.3m | |
| Soliditet | ||
| Equity ratio (%%) | 89.0% | |
| Debt-to-equity ratio | 0.12 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.